Evaluation of rituximab therapy in real clinical practice (according to the OREL registry of patients with rheumatoid arthritis

Objective: to analyze therapy with rituximab (RTM) in real clinical practice according to the data available in OREL registry of patients with active rheumatoid arthritis (RA).Subjects and methods. The analysis included 349 patients. All the patients received RTM: 340 – the original drug (MabThera®)...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: A. S. Avdeeva, A. M. Satybaldyev, N. V. Demidova, N. Yu. Nikishina, E. V. Gerasimova, N. V. Muravyeva, G. I. Gridneva, O. A. Rumyantseva, K. A. Kasumova, A. V. Alekseeva, N. V. Chichasova, D. A. Kusevich, V. V. Rybakova, E. A. Koshkarova, A. M. Lila, E. L. Nasonov
Formaat: Artikel
Taal:Russian
Gepubliceerd in: IMA PRESS LLC 2019-07-01
Reeks:Научно-практическая ревматология
Onderwerpen:
Online toegang:https://rsp.mediar-press.net/rsp/article/view/2725